8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits
- PMID: 2568144
- PMCID: PMC1854428
- DOI: 10.1111/j.1476-5381.1989.tb11896.x
8-OH-DPAT, flesinoxan and guanfacine: systemic and regional haemodynamic effects of centrally acting antihypertensive agents in anaesthetized rabbits
Abstract
1. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and flesinoxan, agents which show high affinity and selectivity for 5-HT1A receptors, were administered intravenously in doses of 0.003 to 0.1 and 0.01 to 0.3 mg kg-1 respectively to 5 rabbits each. Their effects were compared with those of the centrally acting agent and alpha 2-adrenoceptor agonist, guanfacine, 0.01-0.3 mg kg-1, administered to a group of 5 rabbits. Five further rabbits were used as controls and treated with the vehicle of the active agents. 2. Both flesinoxan and 8-OH-DPAT induced similar systemic and regional haemodynamic changes. Both lowered mean arterial pressure and heart rate. The principal blood pressure lowering mechanism was vasodilatation; cardiac output changed minimally despite the falls in heart rate and myocardial contractile force. 3. With guanfacine the maximal fall of blood pressure was comparable to that obtained with the 5-HT1A receptor ligands; however, in contrast to the latter, the dose-response curve was U-shaped, the highest dose eliciting a pressor effect with reversal of the vasodilatation. 4. Widespread peripheral vasodilatation was found with all the agents in the splanchnic circulation and also in the brain and skeletal muscle. A weak tendency towards vasodilatation was found in the kidneys where the dose-response curve was bell-shaped for guanfacine. 5. This spectrum of activity is different from that of peripheral vasodilators, such as calcium antagonists, potassium channel activating agents or hydralazine; it is, however, consistent with the putative mechanism of action of these compounds to reduce peripheral sympathetic tone by a central mechanism of action.
Similar articles
-
Systemic and regional hemodynamic effects of the 5-hydroxytryptamine1A receptor agonists flesinoxan and 8-hydroxy-2(di-N-propylamino)tetralin in the conscious rat.J Cardiovasc Pharmacol. 1991 Mar;17(3):488-93. doi: 10.1097/00005344-199103000-00019. J Cardiovasc Pharmacol. 1991. PMID: 1711612
-
Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.Eur J Pharmacol. 1990 May 16;180(2-3):339-49. doi: 10.1016/0014-2999(90)90319-2. Eur J Pharmacol. 1990. PMID: 2142096
-
Systemic and regional hemodynamic effects of the putative 5-HT1A receptor agonist flesinoxan in the cat.J Cardiovasc Pharmacol. 1989 Nov;14(5):770-6. doi: 10.1097/00005344-198911000-00014. J Cardiovasc Pharmacol. 1989. PMID: 2481192
-
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.Am J Cardiol. 1989 Aug 15;64(7):7D-10D. doi: 10.1016/0002-9149(89)90688-7. Am J Cardiol. 1989. PMID: 2569265 Review.
-
Animal pharmacology of guanfacine.Am J Cardiol. 1986 Mar 28;57(9):13E-17E. doi: 10.1016/0002-9149(86)90717-4. Am J Cardiol. 1986. PMID: 3006469 Review.
Cited by
-
Is blockade of alpha 1-adrenoceptors favourable in hypotension induced by stimulation of serotonin1A receptors in conscious dogs?Drugs. 1990;40 Suppl 4:38-41. doi: 10.2165/00003495-199000404-00010. Drugs. 1990. PMID: 1982653 No abstract available.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical